Dyskinesias in Levodopa-Carbidopa Intestinal Gel Infusion Era: New Challenges, New Features

被引：6
|
作者：
Catalan, Maria-Jose [1 ]
Montero Escribano, Paloma [1 ]
Alonso-Frech, Fernando [1 ,2 ]
机构：
[1] Hosp Clin San Carlos, Unidad Trastornos Movimiento, Serv Neurol, Madrid, Spain
[2] Univ San Pablo CEU, HM Puerta del Sur, HM CINAC, Hosp Univ, Madrid, Spain
来源：
MOVEMENT DISORDERS | 2017年 / 32卷 / 04期
关键词：
D O I：
10.1002/mds.26903
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：624 / 625
页数：2
相关论文
共 50 条
  • [31] Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment
    Matsuyama, Hirofumi
    Matsuura, Keita
    Ishikawa, Hidehiro
    Hirata, Yoshinori
    Kato, Natsuko
    Niwa, Atsushi
    Narita, Yugo
    Tomimoto, Hidekazu
    BRAIN AND BEHAVIOR, 2018, 8 (12):
  • [32] Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Kovacs, Norbert
    Szasz, Jozsef
    Vela-Desojo, Lydia
    Svenningsson, Per
    Femia, Samira
    Parra, Juan Carlos
    Sanchez-Solino, Olga
    Bergmann, Lars
    Gurevich, Tanya
    Fasano, Alfonso
    PARKINSONISM & RELATED DISORDERS, 2022, 105 : 139 - 144
  • [33] Levodopa-Carbidopa Intestinal Gel Therapy After Deep Brain Stimulation
    Kumar, Niraj
    Murgai, Aditya
    Naranian, Taline
    Jog, Mandar
    Fasano, Alfonso
    MOVEMENT DISORDERS, 2018, 33 (02) : 334 - 335
  • [34] Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Othman, Ahmed A.
    Chatamra, Krai
    Mohamed, Mohamed-Eslam F.
    Dutta, Sandeep
    Benesh, Janet
    Yanagawa, Masayoshi
    Nagai, Masahiro
    CLINICAL PHARMACOKINETICS, 2015, 54 (09) : 975 - 984
  • [35] Satisfaction with videoconferencing support for levodopa-carbidopa intestinal gel: An observational study
    Gurevich, Tanya
    Evans, Andrew
    Hassin-Baer, Sharon
    Kagi, Georg
    Koziorowski, Dariusz
    Roszmann, Anna
    Bergmann, Lars
    Parra Riaza, Juan Carlos
    Sanchez-Solino, Olga
    Slawek, Jaroslaw
    DIGITAL HEALTH, 2024, 10
  • [36] Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion
    Martino, Tommaso
    Melchionda, Donato
    Tonti, Paolo
    De Francesco, Vincenzo
    Lalla, Alessandra
    Specchio, Luigi Maria
    Avolio, Carlo
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (12) : 1395 - 1398
  • [37] Clinical characteristics associated with early discontinuation of Levodopa-Carbidopa Intestinal Gel infusion in patients with advanced Parkinson Disease
    Rivero-Rodriguez, D.
    Morales-Casado, M.
    Tabar-Comellas, G.
    Diezma-Martin, A.
    Quintana-Castro, P.
    Ennazeh, M.
    Lopez-Ariztegui, N.
    MOVEMENT DISORDERS, 2024, 39 : S392 - S392
  • [38] Clinical features and survival of treatment with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease.
    Mendoza, M. A. P.
    Contreras, A.
    Lafuente, G.
    Luque Buzo, E.
    De la Casa Fages, B.
    Gonzalez, M.
    Perez Sanchez, J.
    Grandas Perez, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 836 - 836
  • [39] Changes in "On" Time with Levodopa-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease Patients with Troublesome Dyskinesia
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Widnell, Katherine L.
    Chatamra, Krai
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2013, 74 : S45 - S45
  • [40] Changes in "On" time with levodopa-carbidopa intestinal gel infusion in advanced Parkinson's disease patients with troublesome dyskinesia
    Antonini, A.
    Fung, V. S. C.
    Boyd, J. T.
    Slevin, J. T.
    Hall, C.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S144 - S144
12345